Neuberger Berman Canada’s Bristol-Myers Squibb BMY Stock Holding History

Neuberger Berman Canada’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$1.82M	Buy	28,620 +6	+0%	+$350	0.34%	59
2017 Q2	$1.59M	Buy	28,614 +4,066	+17%	+$221K	0.3%	71
2017 Q1	$1.33M	Buy	+24,548	New	+$1.35M	0.26%	88

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Neuberger Berman Canada's BMY Position: Q3 2017 in Review

Neuberger Berman Canada increased its Bristol-Myers Squibb (BMY) stake by 0.02% in Q3 2017, buying an estimated $350 and bringing the position to 28,620 shares worth $1.82M. The position accounts for 0.34% of the portfolio, ranked #59.

Neuberger Berman Canada first reported a position in BMY in Q1 2017 and has held it in 3 quarters since. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

Neuberger Berman Canada held 28,620 shares of Bristol-Myers Squibb worth $1.82M as of Q3 2017.
Neuberger Berman Canada bought 6 Bristol-Myers Squibb shares in Q3 2017, an estimated $350.
Bristol-Myers Squibb made up 0.34% of Neuberger Berman Canada's portfolio in Q3 2017, its #59 holding.
Neuberger Berman Canada first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 3 quarters since.
1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Neuberger Berman Canada's 13F filing for Q3 2017, filed 3 Nov 2017.